Endorsed resource – Benzodiazepine & Z-Drug (BZRA) Deprescribing Algorithm

Bruyère Research Institute Deprescribing Guidelines Research Team has produced an algorithm and accompanying advice that support recommendations in the NICE guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia, and medicines optimisation.

Disclaimer

Endorsed resources are complementary to NICE guidance and are not produced by NICE. This resource has been developed by Bruyère Research Institute Deprescribing Guidelines Research Team, and is not maintained by NICE. NICE has not made any judgement about the quality and usability of the resource. In the event of any issues or errors, please contact Bruyère Research Institute Deprescribing Guidelines Research Team.


This page was last updated: 27 February 2019